Duy Tran

Characterization of dermatitis after PD-1/PD-L1 inhibitor therapy and association with multiple oncologic outcomes: A retrospective case-control study

Charles Kyung Min Lee, Shufeng Li, Duy Tran et al. · Journal of the American Academy of Dermatology · 2018 · 117 citations · Full text

Pd-1/pd-l1 Inhibitor Therapy, Multiple Oncologic Outcomes, Medicine +7

Pembrolizumab for advanced basal cell carcinoma: An investigator-initiated, proof-of-concept study

Anne Lynn S. Chang, Duy Tran, John G. D. Cannon et al. · Journal of the American Academy of Dermatology · 2018 · 114 citations · Full text

The Shelterin TIN2 Subunit Mediates Recruitment of Telomerase to Telomeres

Amanda Frank, Duy Tran, Roy W. Qu et al. · PLoS Genetics · 2015 · 63 citations · Full text

Genome Instability, Engineering, Oncogenic Agent +11

Eculizumab for the Treatment of Severe Antibody-Mediated Rejection: A Case Report and Review of the Literature

Duy Tran, Anne Boucher, Suzon Collette et al. · Case Reports in Transplantation · 2016 · 23 citations · Full text

Immunology, Severe Antibody-mediated Rejection, Dermatology +18

An exploratory open-label, investigator-initiated study to evaluate the efficacy and safety of combination sonidegib and buparlisib for advanced basal cell carcinomas

Duy Tran, A. D. Moffat, Richard Brotherton et al. · Journal of the American Academy of Dermatology · 2017 · 21 citations

Medicine, Combination Sonidegib, Dermatology +5